VYOME HOLDINGS, INC. Increase (Decrease) in Accounts and Other Receivables
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Accounts and Other Receivables of $328.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2025-08-14
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-06-30 was $649.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-03-31 was -$321.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2024-12-31 was -$304.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for the quarter ending 2024-09-30 was $191.00K, a 60.37% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2024 was -$560.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2023 was -$125.00K.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2022 was -$678.00K, a 338.73% decline from fiscal 2021.
- VYOME HOLDINGS, INC. increase (decrease) in accounts and other receivables for fiscal 2021 was $284.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2025-06-30 | $649.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $328.00K 10-Q · filed 2025-08-14 | $24.00K derived: sum of 3 quarters · filed 2025-08-14 | $215.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | -$321.00K 10-Q · filed 2025-05-20 | -$625.00K derived: sum of 2 quarters · filed 2025-05-20 | -$434.00K derived: sum of 3 quarters · filed 2025-05-20 | -$441.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | -$304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$113.00K derived: sum of 2 quarters · filed 2025-04-04 | -$120.00K derived: sum of 3 quarters · filed 2025-08-14 | -$560.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $184.00K derived: sum of 2 quarters · filed 2025-08-14 | -$256.00K 10-Q · filed 2024-11-14 | -$803.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$447.00K 10-Q · filed 2025-08-14 | -$994.00K derived: sum of 3 quarters · filed 2025-08-14 | -$512.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$440.00K 10-Q · filed 2025-05-20 | -$987.00K derived: sum of 2 quarters · filed 2025-05-20 | -$505.00K derived: sum of 3 quarters · filed 2025-05-20 | -$544.00K derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | -$547.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | -$65.00K derived: sum of 2 quarters · filed 2025-04-04 | -$104.00K derived: sum of 3 quarters · filed 2025-04-04 | -$125.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $443.00K derived: sum of 2 quarters · filed 2024-11-14 | $422.00K 10-Q · filed 2024-11-14 | $401.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$60.00K 10-Q · filed 2024-08-14 | -$81.00K derived: sum of 3 quarters · filed 2024-08-14 | -$267.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$21.00K 10-Q · filed 2024-05-15 | -$42.00K derived: sum of 2 quarters · filed 2024-05-15 | -$228.00K derived: sum of 3 quarters · filed 2024-05-15 | -$320.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$207.00K derived: sum of 2 quarters · filed 2024-04-01 | -$299.00K derived: sum of 3 quarters · filed 2024-04-01 | -$678.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$278.00K derived: sum of 2 quarters · filed 2023-11-09 | -$657.00K 10-Q · filed 2023-11-09 | -$1.27M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$471.00K 10-Q · filed 2023-08-07 | -$1.09M derived: sum of 3 quarters · filed 2023-08-07 | -$1.05M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$379.00K 10-Q · filed 2023-05-15 | -$995.00K derived: sum of 2 quarters · filed 2023-05-15 | -$954.00K derived: sum of 3 quarters · filed 2023-05-15 | -$875.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$575.00K derived: sum of 2 quarters · filed 2023-04-17 | -$496.00K derived: sum of 3 quarters · filed 2023-04-17 | $284.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $120.00K derived: sum of 2 quarters · filed 2022-11-14 | $900.00K 10-Q · filed 2022-11-14 | $645.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $859.00K 10-Q · filed 2022-08-19 | $604.00K derived: sum of 3 quarters · filed 2022-08-19 | $670.00K derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $780.00K 10-Q · filed 2022-05-23 | $525.00K derived: sum of 2 quarters · filed 2022-05-23 | $591.00K derived: sum of 3 quarters · filed 2022-05-23 | |
| 2020-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$189.00K derived: sum of 2 quarters · filed 2022-04-08 | -$1.22M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$962.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$1.03M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |